Efficacy and safety of avacopan for treatment of patients with ANCA-associated vasculitis receiving cyclophosphamide
Sarah Bray, Thomas Neumann, Duvuru Geetha, María C. Cid et al.
Citations
1 citations
Journal
RMD Open
Topics
Vasculitis and related conditions
Field-Weighted Citation Impact (FWCI)
1.52
article
Efficacy and safety of avacopan for treatment of patients with ANCA-associated vasculitis receiving cyclophosphamide
Sarah Bray, Thomas Neumann, Duvuru Geetha, María C. Cid, David R.W. Jayne, Peter A. Merkel, Alexandre Karras, Alana M. Bozeman
article en
1 citations
Abstract
No abstract available for this paper.
Publication Tag
RMD OpenVol. 11(4)
Institutions
Délégation Paris 5 (FR), Amgen (United States) (US), Johns Hopkins University (US), Université Paris Cité (FR), University of Cambridge (GB), Johns Hopkins Medicine (US), Kantonsspital St. Gallen (CH), Hôpital Européen Georges-Pompidou (FR), Hôpital Européen (FR), Amgen (United Kingdom) (GB), Consorci Institut D'Investigacions Biomediques August Pi I Sunyer (ES), University of Pennsylvania (US)
Ask Laika to Summarize, Analyze, and Connect papers live on the map.
Summarize Papers & Methodologies
Extract key findings, datasets, and comparative methods across publications.
Benchmark Rankings & Visual Analytics
Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.
Connect Distant Disciplines
Bridge topological clusters on the map to find hidden collaborative intersections.
Efficacy and safety of avacopan for treatment of patients with ANCA-associated vasculitis receiving cyclophosphamide — Sarah Bray, Thomas Neumann, et al. · RMD Open (2025) | TGRS Research Map | TGRS